Literature DB >> 17965340

Differential binding of Shiga toxin 2 to human and murine neutrophils.

Thomas P Griener1, George L Mulvey1, Paola Marcato2, Glen D Armstrong1.   

Abstract

Shiga toxins (Stx1 and Stx2) are responsible for initiating haemolytic uraemic syndrome, a serious extraintestinal complication caused by enterohaemorrhagic Escherichia coli O157 : H7 infection in humans. Shiga toxins are classical AB(5)-type exotoxins, consisting of a globotriaosylceramide (Gb(3))-binding B subunit pentamer and an enzymic A subunit. It is demonstrated in this study that Stx2 binds to human neutrophils by a non-classical mechanism that is independent of Gb(3). In contrast, the investigation revealed that Stx2 binds to murine neutrophils by the classical Gb(3)-dependent mechanism. Moreover, whereas the human serum amyloid P (HuSAP) component inhibited Stx2 binding to murine neutrophils, HuSAP increased Stx2 binding to human neutrophils by 84.2 % (P< or =0.002, Student's t-test). These observations may explain why HuSAP protects mice from the lethal effects of Stx2, whereas there is no indication that HuSAP plays a similar protective role in humans infected by E. coli O157 : H7.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17965340     DOI: 10.1099/jmm.0.47282-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  18 in total

1.  Change in conformation with reduction of alpha-helix content causes loss of neutrophil binding activity in fully cytotoxic Shiga toxin 1.

Authors:  Maurizio Brigotti; Domenica Carnicelli; Valentina Arfilli; Laura Rocchi; Francesca Ricci; Pasqualepaolo Pagliaro; Pier Luigi Tazzari; Antonio González Vara; Matteo Amelia; Francesco Manoli; Sandra Monti
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

Review 2.  Induction of apoptosis by Shiga toxins.

Authors:  Vernon L Tesh
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

3.  Induction of Neutrophil Extracellular Traps in Shiga Toxin-Associated Hemolytic Uremic Syndrome.

Authors:  Maria Victoria Ramos; Maria Pilar Mejias; Florencia Sabbione; Romina Jimena Fernandez-Brando; Adriana Patricia Santiago; Maria Marta Amaral; Ramon Exeni; Analia Silvina Trevani; Marina Sandra Palermo
Journal:  J Innate Immun       Date:  2016-05-28       Impact factor: 7.349

4.  Role of tumor necrosis factor alpha in disease using a mouse model of Shiga toxin-mediated renal damage.

Authors:  Erin K Lentz; Rama P Cherla; Valery Jaspers; Bradley R Weeks; Vernon L Tesh
Journal:  Infect Immun       Date:  2010-07-06       Impact factor: 3.441

5.  Glycan encapsulated gold nanoparticles selectively inhibit shiga toxins 1 and 2.

Authors:  Ashish A Kulkarni; Cynthia Fuller; Henry Korman; Alison A Weiss; Suri S Iyer
Journal:  Bioconjug Chem       Date:  2010-08-18       Impact factor: 4.774

6.  Protection of human podocytes from shiga toxin 2-induced phosphorylation of mitogen-activated protein kinases and apoptosis by human serum amyloid P component.

Authors:  Anne K Dettmar; Elisabeth Binder; Friederike R Greiner; Max C Liebau; Christine E Kurschat; Therese C Jungraithmayr; Moin A Saleem; Claus-Peter Schmitt; Elisabeth Feifel; Dorothea Orth-Höller; Markus J Kemper; Mark Pepys; Reinhard Würzner; Jun Oh
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

7.  Association of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cells.

Authors:  Ivan U Kouzel; Gottfried Pohlentz; Wiebke Storck; Lena Radamm; Petra Hoffmann; Martina Bielaszewska; Andreas Bauwens; Christoph Cichon; M Alexander Schmidt; Michael Mormann; Helge Karch; Johannes Müthing
Journal:  J Lipid Res       Date:  2012-12-17       Impact factor: 5.922

Review 8.  The interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety?

Authors:  Maurizio Brigotti
Journal:  Toxins (Basel)       Date:  2012-03-01       Impact factor: 4.546

Review 9.  Shiga toxins: intracellular trafficking to the ER leading to activation of host cell stress responses.

Authors:  Moo-Seung Lee; Rama P Cherla; Vernon L Tesh
Journal:  Toxins (Basel)       Date:  2010-06-17       Impact factor: 4.546

Review 10.  Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies.

Authors:  Lindsay S Keir; Stephen D Marks; Jon Jin Kim
Journal:  Drug Des Devel Ther       Date:  2012-07-19       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.